Sinopharm Group Co Ltd
OTC:SHTDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
OTC:SHTDY
|
CN |
|
Amadeus IT Group SA
MAD:AMS
|
ES |
|
Bank Rakyat Indonesia (Persero) Tbk PT
F:BYRA
|
ID |
|
F
|
Fiskars Oyj Abp
SWB:A8X
|
FI |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SHTDY's stock price target?
Price Target
13.6
USD
According to Wall Street analysts, the average 1-year price target for 
SHTDY is 13.6 USD with a low forecast of 10.85 USD and a high forecast of 17.89 USD.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Sinopharm Group Co Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Pre-Tax Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 7%.